Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
Association of Antidiabetic Medication Classes With Survival Outcomes in Pulmonary Hypertension Patients With Diabetes. [PDF]
Trammell AW +5 more
europepmc +1 more source
Association of Circulating Brain-Derived Neurotrophic Factor With Coronary Risk Factors and Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography. [PDF]
Tachibana T +9 more
europepmc +1 more source
Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease. [PDF]
Seo DH, Ha KH, Kim SH, Kim DJ.
europepmc +1 more source
A Case of Oral Semaglutide for Treatment of Hepatocyte Nuclear Factor 4A Maturity-Onset Diabetes of the Young. [PDF]
Grennan KN +3 more
europepmc +1 more source
Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan +6 more
wiley +1 more source
Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease. [PDF]
Wallace H +9 more
europepmc +1 more source
Potentially inappropriate medications for patients with heart failure: a nationwide retrospective study from 2012 to 2022. [PDF]
Sunaga T +5 more
europepmc +1 more source
Risk of Depression With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Compared to Other Antidiabetic Medications in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]
Ferrer Zavala GM +6 more
europepmc +1 more source

